N-of-One Presents Data at American Association for Cancer Research-EORTC-National Cancer Institute Meeting Showing Common Breast Cancer Mutation Also Present in Other Cancers, Expanding Targeted Treatment Options
Published: Oct 23, 2013
N-of-One, Inc., the leading provider of molecular interpretation and therapeutic strategies for personalized cancer care, presented data at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference identifying additional treatment options beyond the standard of care for some patients with unexpected genetic alterations.
Help employers find you! Check out all the jobs and post your resume.